The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of single-nucleotide polymorphism (SNP) in the 5-alpha-reductase gene (SRD5A2) with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer (TC) survivors.
H. Boer
No relevant relationships to disclose
C. Meijer
No relevant relationships to disclose
J. D. Dijck-Brouwer
No relevant relationships to disclose
I. P. Kema
No relevant relationships to disclose
J. D. Lefrandt
No relevant relationships to disclose
N. Zwart
No relevant relationships to disclose
H. M. Boezen
No relevant relationships to disclose
A. J. Smit
No relevant relationships to disclose
J. A. Gietema
Research Funding - Pfizer; Roche